A chip-based platform 1,000x more sensitive than PCR — detecting disease up to 24 hours before any test on the market. From a raw sample. In under 60 seconds.
ZERO WAIT TIME | ZERO SAMPLE PREP | ZERO LAB REQUIRED Know in seconds, not days.
— DIAGNOSTICS, REINVENTED
27,000,000
People die every year from infectious disease. 80% of those deaths are preventable.
-
GBD 2021 Sepsis (Lancet) — 21.4M sepsis-related deaths; combined with pneumonia (>2.5M, CIDRAP), TB (~1.3M, WHO 2023), and other infections. WHO Sepsis Fact Sheet; Global Sepsis Alliance.
PMC Systematic Review (n=22,655) — 40.1% positive blood cultures = ~60% culture-negative despite clinical sepsis. ASM Clinical Microbiology Reviews — sensitivity typically 40–65%.
Sepsis Alliance — Each hour of delay in appropriate antibiotics increases mortality 7–10%. CLSI Standards — Standard blood culture: 3–5 days to actionable result.
— WHAT WE BUILT
Labzero 101
Labzero built a portable testing platform that instantly detects microbes in real-world environments, without a lab, without sample prep, and without specialized training so people can make critical safety decisions in under a minute.
— DIAGNOSTICS, REINVENTED
What this means for you
— HOW IT WORKSCollect. Tap. Know.
— APPLICATIONS
Same reader. Different chip.
Ready to know more?
Whether you're a partner, a clinician, a researcher, or someone who just believes
people deserve better — we'd love to hear from you.
Get in touch directly
Fill out the form and our team will get back to you within 24 hours.
Email us
info@labzero.bio